Origins of chromosome translocations in childhood leukaemia

[1]  M. Burns,et al.  Case-Control Study , 2020, Definitions.

[2]  Ana-Teresa Maia,et al.  Prenatal origin of hyperdiploid acute lymphoblastic leukemia in identical twins , 2003, Leukemia.

[3]  M. Greaves,et al.  Leukemia in twins: lessons in natural history. , 2003, Blood.

[4]  M. Greaves,et al.  Prenatal chromosomal diversification of leukemia in monozygotic twins , 2003, Genes, chromosomes & cancer.

[5]  Tom Misteli,et al.  Spatial proximity of translocation-prone gene loci in human lymphomas , 2003, Nature Genetics.

[6]  K. Matthay,et al.  Prenatal origin of childhood acute myeloid leukemias harboring chromosomal rearrangements t(15;17) and inv(16). , 2003, Blood.

[7]  T. Rabbitts,et al.  Chromosomal translocation products engender new intracellular therapeutic technologies , 2003, Nature Medicine.

[8]  M. Diaz,et al.  Apoptotic stimuli initiate MLL-AF9 translocations that are transcribed in cells capable of division. , 2003, Cancer research.

[9]  B. Nadel,et al.  Distinct t(7;9)(q34;q32) breakpoints in healthy individuals and individuals with T-ALL , 2003, Nature Genetics.

[10]  Rob Pieters,et al.  Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classification. , 2003, Cancer cell.

[11]  Daniel G. Tenen,et al.  Disruption of differentiation in human cancer: AML shows the way , 2003, Nature Reviews Cancer.

[12]  M. Segal,et al.  Genomic anatomy of the specific reciprocal translocation t(15;17) in acute promyelocytic leukemia , 2003, Genes, chromosomes & cancer.

[13]  Kaoru Inoue,et al.  Prevalent Involvement of Illegitimate V(D)J Recombination in Chromosome 9p21 Deletions in Lymphoid Leukemia* , 2002, The Journal of Biological Chemistry.

[14]  Xiaomei Ma,et al.  Site-specific translocation and evidence of postnatal origin of the t(1;19) E2A-PBX1 fusion in childhood acute lymphoblastic leukemia , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[15]  M. Melbye,et al.  Presence of clone-specific markers at birth in children with acute lymphoblastic leukaemia , 2002, British Journal of Cancer.

[16]  J. Squire,et al.  The role of Alu repeat clusters as mediators of recurrent chromosomal aberrations in tumors , 2002, Genes, chromosomes & cancer.

[17]  J. Griffin,et al.  The roles of FLT3 in hematopoiesis and leukemia. , 2002, Blood.

[18]  M. Zahurak,et al.  TEL-AML1, expressed from t(12;21) in human acute lymphocytic leukemia, induces acute leukemia in mice. , 2002, Cancer research.

[19]  J. Harbott,et al.  Immature CD34+CD19- progenitor/stem cells in TEL/AML1-positive acute lymphoblastic leukemia are genetically and functionally normal. , 2002, Blood.

[20]  N. Archidiacono,et al.  A 76-kb duplicon maps close to the BCR gene on chromosome 22 and the ABL gene on chromosome 9: Possible involvement in the genesis of the Philadelphia chromosome translocation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[21]  R. Eils,et al.  Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene expression profiles , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[22]  D. Gilliland,et al.  Core-binding factors in haematopoiesis and leukaemia , 2002, Nature Reviews Cancer.

[23]  O. Haas,et al.  Nondisjunction of chromosomes leading to hyperdiploid childhood B-cell precursor acute lymphoblastic leukemia is an early event during leukemogenesis. , 2002, Blood.

[24]  M. Greaves,et al.  Chromosome translocations and covert leukemic clones are generated during normal fetal development , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Ana-Teresa Maia,et al.  In utero origin of t(8;21) AML1-ETO translocations in childhood acute myeloid leukemia. , 2002, Blood.

[26]  S Selvin,et al.  Daycare attendance and risk of childhood acute lymphoblastic leukaemia , 2002, British Journal of Cancer.

[27]  Y. Ravindranath,et al.  High frequency of leukemic clones in newborn screening blood samples of children with B-precursor acute lymphoblastic leukemia. , 2002, Blood.

[28]  D. Hémon,et al.  Day-care, early common infections and childhood acute leukaemia: a multicentre French case–control study , 2002, British Journal of Cancer.

[29]  J. Rowley,et al.  International workshop on the relationship of prior therapy to balanced chromosome aberrations in therapy‐related myelodysplastic syndromes and acute leukemia: Overview report , 2002, Genes, chromosomes & cancer.

[30]  J. Downing,et al.  Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. , 2002, Cancer cell.

[31]  J. Rowley,et al.  Genomic DNA breakpoints in AML1/RUNX1 and ETO cluster with topoisomerase II DNA cleavage and DNase I hypersensitive sites in t(8;21) leukemia , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[32]  J. Downing,et al.  Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia. , 2002, Cancer cell.

[33]  B. Nadel,et al.  V(D)J-mediated Translocations in Lymphoid Neoplasms , 2002, The Journal of experimental medicine.

[34]  B. Armstrong,et al.  Maternal folate supplementation in pregnancy and protection against acute lymphoblastic leukaemia in childhood: a case-control study , 2001, The Lancet.

[35]  M. Segal,et al.  Molecular characterization of genomic AML1-ETO fusions in childhood leukemia , 2001, Leukemia.

[36]  I. Weissman,et al.  Stem cells, cancer, and cancer stem cells , 2001, Nature.

[37]  C. Lengauer.  How do tumors make ends meet? , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[38]  J. Aster,et al.  The expression of ETV6/CBFA2 (TEL/AML1) is not sufficient for the transformation of hematopoietic cell lines in vitro or the induction of hematologic disease in vivo. , 2001, Cancer genetics and cytogenetics.

[39]  M. Cleary,et al.  Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins , 2001, Oncogene.

[40]  Riccardo Dalla-Favera,et al.  Mechanisms of chromosomal translocations in B cell lymphomas , 2001, Oncogene.

[41]  S. Shurtleff,et al.  Molecular emergence of acute myeloid leukemia during treatment for acute lymphoblastic leukemia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[42]  I. Weissman,et al.  AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[43]  L. Liu,et al.  Nucleolytic Cleavage of the Mixed Lineage Leukemia Breakpoint Cluster Region during Apoptosis* , 2001, The Journal of Biological Chemistry.

[44]  P. Nowell,et al.  Near-precise interchromosomal recombination and functional DNA topoisomerase II cleavage sites at MLL and AF-4 genomic breakpoints in treatment-related acute lymphoblastic leukemia with t(4;11) translocation , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[45]  M. Lieber,et al.  Analysis of the V(D)J Recombination Efficiency at Lymphoid Chromosomal Translocation Breakpoints* , 2001, The Journal of Biological Chemistry.

[46]  M. Greaves,et al.  Origins of "late" relapse in childhood acute lymphoblastic leukemia with TEL-AML1 fusion genes. , 2001, Blood.

[47]  G. M. Taylor,et al.  Molecular tracking of leukemogenesis in a triplet pregnancy. , 2001, Blood.

[48]  H. Horvitz,et al.  Phagocytosis promotes programmed cell death in C. elegans , 2001, Nature.

[49]  M. Diaz,et al.  Apoptotic triggers initiate translocations within the MLL gene involving the nonhomologous end joining repair system. , 2001, Cancer research.

[50]  P. Jeggo,et al.  Radiation-induced genomic rearrangements formed by nonhomologous end-joining of DNA double-strand breaks. , 2001, Cancer research.

[51]  C. Sawyers,et al.  Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. , 2001, The New England journal of medicine.

[52]  G. M. Taylor,et al.  Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[53]  M. Greaves,et al.  Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion. , 2001, Cancer research.

[54]  K. Khanna,et al.  DNA double-strand breaks: signaling, repair and the cancer connection , 2001, Nature Genetics.

[55]  P. Fenaux,et al.  Treatment of acute promyelocytic leukaemia. , 2001, Best practice & research. Clinical haematology.

[56]  E Ishii,et al.  Breakage and fusion of the TEL (ETV6) gene in immature B lymphocytes induced by apoptogenic signals. , 2001, Blood.

[57]  J. Melo,et al.  The molecular biology of chronic myeloid leukemia. , 2000, Blood.

[58]  L. Rompaey,et al.  Tel induces a G1 arrest and suppresses Ras-induced transformation , 2000, Oncogene.

[59]  M. Greaves,et al.  Microclustering of TEL‐AML1 translocation breakpoints in childhood acute lymphoblastic leukemia , 2000, Genes, chromosomes & cancer.

[60]  C. Felix,et al.  Potential role for DNA topoisomerase II poisons in the generation of t(11;20)(p15;q11) translocations , 2000, Genes, chromosomes & cancer.

[61]  B. Roe,et al.  DNA structural properties of AF9 are similar to MLL and could act as recombination hot spots resulting in MLL/AF9 translocations and leukemogenesis. , 2000, Human molecular genetics.

[62]  C. Pui,et al.  Biological and therapeutic aspects of infant leukemia. , 2000, Blood.

[63]  T. Sawada,et al.  Detection of clonotypic IGH and TCR rearrangements in the neonatal blood spots of infants and children with B-cell precursor acute lymphoblastic leukemia. , 2000, Blood.

[64]  I. Weissman,et al.  AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[65]  Christine Richardson,et al.  Frequent chromosomal translocations induced by DNA double-strand breaks , 2000, Nature.

[66]  F. Alt,et al.  The nonhomologous end-joining pathway of DNA repair is required for genomic stability and the suppression of translocations. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[67]  Mel Greaves,et al.  Cancer: The Evolutionary Legacy , 2000 .

[68]  J. Rowley,et al.  Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[69]  O. Haas,et al.  Presence of clone-specific antigen receptor gene rearrangements at birth indicates an in utero origin of diverse types of early childhood acute lymphoblastic leukemia. , 2000, Blood.

[70]  O. Witte,et al.  Regulated expression of P210 Bcr-Abl during embryonic stem cell differentiation stimulates multipotential progenitor expansion and myeloid cell fate. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[71]  T. Flores,et al.  A primitive hematopoietic cell is the target for the leukemic transformation in human philadelphia-positive acute lymphoblastic leukemia. , 2000, Blood.

[72]  I. Weissman,et al.  Stem Cells Units of Development, Units of Regeneration, and Units in Evolution , 2000, Cell.

[73]  Elaine Fuchs,et al.  Stem Cells A New Lease on Life , 2000, Cell.

[74]  R. Sékaly,et al.  Early Activation of Caspases during T Lymphocyte Stimulation Results in Selective Substrate Cleavage in Nonapoptotic Cells , 1999, The Journal of experimental medicine.

[75]  M. Greaves,et al.  Molecular genetics, natural history and the demise of childhood leukaemia. , 1999, European journal of cancer.

[76]  M. Greaves,et al.  Prenatal origin of acute lymphoblastic leukaemia in children , 1999, The Lancet.

[77]  O. Bernard,et al.  TEL Is a Sequence-specific Transcriptional Repressor* , 1999, The Journal of Biological Chemistry.

[78]  M. Greaves,et al.  Structure and possible mechanisms of TEL-AML1 gene fusions in childhood acute lymphoblastic leukemia. , 1999, Cancer research.

[79]  M F Greaves,et al.  A lack of a functional NAD(P)H:quinone oxidoreductase allele is selectively associated with pediatric leukemias that have MLL fusions. United Kingdom Childhood Cancer Study Investigators. , 1999, Cancer research.

[80]  M. Greaves,et al.  Protracted and variable latency of acute lymphoblastic leukemia after TEL-AML1 gene fusion in utero. , 1999, Blood.

[81]  Johnson M Liu,et al.  Chromatin remodeling and leukemia: new therapeutic paradigms. , 1999, Blood.

[82]  M. Greaves,et al.  Molecular genetics, natural history and the demise of childhood leukaemia. , 1999, European journal of cancer.

[83]  C. Wijmenga,et al.  Genomic acute myeloid leukemia-associated inv(16)(p13q22) breakpoints are tightly clustered , 1999, Oncogene.

[84]  J. Birch.  Genes and cancer , 1999, Archives of disease in childhood.

[85]  R. Marschalek,et al.  Fine structure of translocation breakpoints in leukemic blasts with chromosomal translocation t(4;11): the DNA damage-repair model of translocation , 1998, Oncogene.

[86]  J. Hoeijmakers,et al.  Molecular mechanisms of DNA double strand break repair. , 1998, Trends in cell biology.

[87]  J. Rowley,et al.  An in vivo topoisomerase II cleavage site and a DNase I hypersensitive site colocalize near exon 9 in the MLL breakpoint cluster region. , 1998, Blood.

[88]  J. Melo,et al.  The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: biologic significance and implications for the assessment of minimal residual disease. , 1998, Blood.

[89]  C. Felix.  Secondary leukemias induced by topoisomerase-targeted drugs. , 1998, Biochimica et biophysica acta.

[90]  M. Gellert,et al.  DNA Transposition by the RAG1 and RAG2 Proteins A Possible Source of Oncogenic Translocations , 1998, Cell.

[91]  David G. Schatz,et al.  Transposition mediated by RAG1 and RAG2 and its implications for the evolution of the immune system , 1998, Nature.

[92]  M. Greaves,et al.  Loops, Lineage, and Leukemia , 1998, Cell.

[93]  F. Barr.  Translocations, cancer and the puzzle of specificity , 1998, Nature Genetics.

[94]  E. Rappaport,et al.  t(11;22)(q23;q11.2) In acute myeloid leukemia of infant twins fuses MLL with hCDCrel, a cell division cycle gene in the genomic region of deletion in DiGeorge and velocardiofacial syndromes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[95]  S. Sowerby,et al.  The BCR gene recombines preferentially with Alu elements in complex BCR-ABL translocations of chronic myeloid leukaemia. , 1998, Human molecular genetics.

[96]  M. Greaves,et al.  Fetal origins of the TEL-AML1 fusion gene in identical twins with leukemia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[97]  M. Caligiuri,et al.  The partial tandem duplication of ALL1 (MLL) is consistently generated by Alu-mediated homologous recombination in acute myeloid leukemia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[98]  M. Greaves,et al.  Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[99]  A T Look,et al.  Oncogenic transcription factors in the human acute leukemias. , 1997, Science.

[100]  C. Jackson-Cook,et al.  A precise interchromosomal reciprocal exchange between hot spots for cleavable complex formation by topoisomerase II in amsacrine-treated Chinese hamster ovary cells. , 1997, Cancer research.

[101]  G. Chu.  Double Strand Break Repair* , 1997, The Journal of Biological Chemistry.

[102]  M. Stanulla,et al.  DNA cleavage within the MLL breakpoint cluster region is a specific event which occurs as part of higher-order chromatin fragmentation during the initial stages of apoptosis , 1997, Molecular and cellular biology.

[103]  J. Dick,et al.  Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell , 1997, Nature Medicine.

[104]  S. Lewis,et al.  Cryptic signals and the fidelity of V(D)J joining , 1997, Molecular and cellular biology.

[105]  M. Stanulla,et al.  Topoisomerase II inhibitors induce DNA double-strand breaks at a specific site within the AML1 locus , 1997, Leukemia.

[106]  M. Greaves.  Aetiology of acute leukaemia , 1997, The Lancet.

[107]  H P Koeffler,et al.  TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia. , 1996, Blood.

[108]  T. Rabbitts,et al.  An Mll–AF9 Fusion Gene Made by Homologous Recombination Causes Acute Leukemia in Chimeric Mice: A Method to Create Fusion Oncogenes , 1996, Cell.

[109]  Melo Jv.  The molecular biology of chronic myeloid leukaemia. , 1996 .

[110]  P. Marynen,et al.  The 12;21 translocation involving TEL and deletion of the other TEL allele: two frequently associated alterations found in childhood acute lymphoblastic leukemia. , 1996, Blood.

[111]  M. Stanulla,et al.  Site-specific DNA cleavage within the MLL breakpoint cluster region induced by topoisomerase II inhibitors. , 1996, Blood.

[112]  N. Zeleznik-Le,et al.  Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sites. , 1996, Blood.

[113]  M. Greaves,et al.  Rapid intraclonal switch of lineage dominance in congenital leukaemia with a MLL gene rearrangement. , 1995, Leukemia.

[114]  S. Shurtleff,et al.  TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. , 1995, Leukemia.

[115]  S. Korsmeyer,et al.  Altered Hox expression and segmental identity in Mll-mutant mice , 1995, Nature.

[116]  G. Huez,et al.  Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals. , 1995, Blood.

[117]  C. Felix,et al.  Chromosome band 11q23 translocation breakpoints are DNA topoisomerase II cleavage sites. , 1995, Cancer research.

[118]  D. Le Paslier,et al.  The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. , 1995, Blood.

[119]  D C Ward,et al.  Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[120]  N. Gregersen,et al.  One short well conserved region of Alu-sequences is involved in human gene rearrangements and has homology with prokaryotic chi. , 1995, Nucleic acids research.

[121]  J. Potter,et al.  Infant leukemia, topoisomerase II inhibitors, and the MLL gene. , 1994, Journal of the National Cancer Institute.

[122]  T. Rabbitts,et al.  Chromosomal translocations in human cancer , 1994, Nature.

[123]  D. Shibata,et al.  BCL2 translocation frequency rises with age in humans. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[124]  J. Rowley,et al.  The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation. , 1994, Blood.

[125]  J. Rowley,et al.  Clonal, nonconstitutional rearrangements of the MLL gene in infant twins with acute lymphoblastic leukemia: in utero chromosome rearrangement of 11q23 , 1994 .

[126]  M. Greaves,et al.  In utero rearrangements in the trithorax-related oncogene in infant leukaemias , 1993, Nature.

[127]  M. Greaves,et al.  Stem cell origins of leukaemia and curability. , 1993, British Journal of Cancer.

[128]  Y. Pommier,et al.  Small deletion and insertion mutations induced by the topoisomerase II inhibitor teniposide in CHO cells and comparison with sites of drug-stimulated DNA cleavage in vitro. , 1993, Journal of molecular biology.

[129]  M. Greaves,et al.  Clonal characteristics of acute lymphoblastic cells derived from BCR/ABL p190 transgenic mice. , 1992, Oncogene.

[130]  Knudson Ag.  Stem cell regulation, tissue ontogeny, and oncogenic events. , 1992 .

[131]  A. Cumano,et al.  Bipotential precursors of B cells and macrophages in murine fetal liver , 1992, Nature.

[132]  M. Siciliano,et al.  Site‐specific recombination of the tal‐1 gene is a common occurrence in human T cell leukemia. , 1990, The EMBO journal.

[133]  G. Daley,et al.  Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. , 1990, Science.

[134]  C. Eaves,et al.  Cytogenetic studies of haemopoietic colonies from patients with an initial diagnosis of acute lymphoblastic leukaemia , 1988, British journal of haematology.

[135]  J. Adamson,et al.  Clonal development, stem-cell differentiation, and clinical remissions in acute nonlymphocytic leukemia. , 1987, The New England journal of medicine.

[136]  M. Greaves.  Differentiation-linked leukemogenesis in lymphocytes. , 1986, Science.

[137]  T. D. Schneider,et al.  Information content of binding sites on nucleotide sequences. , 1986, Journal of molecular biology.

[138]  J. Rowley.  Biological implications of consistent chromosome rearrangements in leukemia and lymphoma. , 1984, Cancer research.

[139]  E. McCulloch.  Stem cells in normal and leukemic hemopoiesis (Henry Stratton Lecture, 1982) , 1983 .

[140]  B. Clarkson,et al.  Possible explanation of the high concoddance for acute leukaemia in monozygotic twins. , 1971, Lancet.

[141]  E. McCulloch.  Stem Cells in Normal and Leukemic Hemopoiesis , 2005 .

[142]  Tactggtat Agcctagatgtgtttaga,et al.  J-mediated Translocations in Lymphoid Neoplasms : A Functional Assessment of Genomic Instability by Cryptic Sites , 2001 .

[143]  F. Alt,et al.  Nonhomologous end-joining proteins are required for V(D)J recombination, normal growth, and neurogenesis. , 1999, Cold Spring Harbor symposia on quantitative biology.

[144]  J. Rowley,et al.  The critical role of chromosome translocations in human leukemias. , 1998, Annual review of genetics.

[145]  L. Chan.  The Molecular Biology of Chronic Myeloid Leukaemia , 1998 .

[146]  J. Kersey.  Fifty years of studies of the biology and therapy of childhood leukemia. , 1997, Blood.

[147]  L. Chan,et al.  MLL self fusion mediated by Alu repeat homologous recombination and prognosis of AML-M4/M5 subtypes. , 1997, Cancer research.

[148]  M. Greaves,et al.  Monoclonal origin of concordant T-cell malignancy in identical twins. , 1997, Blood.

[149]  P. Marynen,et al.  Deletion of the short arm of chromosome 12 is a secondary event in acute lymphoblastic leukemia with t(12;21). , 1996, Leukemia.

[150]  J. Rowley,et al.  Clonal, nonconstitutional rearrangements of the MLL gene in infant twins with acute lymphoblastic leukemia: in utero chromosome rearrangement of 11q23. , 1994, Blood.

[151]  A. Knudson.  Stem cell regulation, tissue ontogeny, and oncogenic events. , 1992, Seminars in cancer biology.

[152]  A. Stoler.  Genes and cancer. , 1991, British medical bulletin.

[153]  J. Cossman.  Molecular Genetics in Cancer Diagnosis , 1990 .

[154]  J. Thompson.  A new lease of life. , 1989, Nursing times.

[155]  L. Fink,et al.  Cancer : a problem of developmental biology , 1978 .